Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with

Macular Edema: 24-Month Results of the CRYSTAL Study

Michael Larsen, MD, Sebastian M. Waldstein, MD, Siegfried Priglinger, MD, Philip Hykin, MD, Elizabeth Barnes, PhD, Margarita
Gekkieva, MD, Ayan Das Gupta, MSc, Andreas Wenzel, PhD, Jordi Monés, MD, PhD

Ophthalmology Retina
Volume 2, Issue 2, Pages 134-142 (February 2018)
DOI: 10.1016/j.oret.2017.05.016

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions

 Figure 1

Ophthalmology Retina 2018 2, 134-142DOI: (10.1016/j.oret.2017.05.016)

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions
 Figure 2

Ophthalmology Retina 2018 2, 134-142DOI: (10.1016/j.oret.2017.05.016)

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions
 Figure 3

Ophthalmology Retina 2018 2, 134-142DOI: (10.1016/j.oret.2017.05.016)

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions
 Figure 4

Ophthalmology Retina 2018 2, 134-142DOI: (10.1016/j.oret.2017.05.016)

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions
 Figure 5

Ophthalmology Retina 2018 2, 134-142DOI: (10.1016/j.oret.2017.05.016)

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions
 Figure 6

Ophthalmology Retina 2018 2, 134-142DOI: (10.1016/j.oret.2017.05.016)

Copyright © 2017 American Academy of Ophthalmology Terms and Conditions